Infections in the neutropenic patient--new views of an old problem.
Infection in the neutropenic patient has remained a major clinical challenge for over three decades. While diagnostic and therapeutic interventions have improved greatly during this period, increases in the number of patients with neutropenia, changes in the etiologic agents involved, and growing antibiotic resistance have continued to be problematic. The evolving etiology of infections in this patient population is reviewed by Dr. Donowitz. Presently accepted antibiotic regimens and practices are discussed, along with ongoing controversies. In Section II, Drs. Maki and Crnich discuss line-related infection, which is a major infectious source in the neutropenic. Defining true line-related bloodstream infection remains a challenge despite the fact that various methods to do so exist. Means of prevention of line related infection, diagnosis, and therapy are reviewed. Fungal infection continues to perplex the infectious disease clinician and hematologist/oncologist. Diagnosis is difficult, and many fungal infections will lead to increased mortality even with rapid diagnosis and therapy. In Section III, Dr. Pappas reviews the major fungal etiologies of infection in the neutropenic patient and the new anti-fungals that are available to treat them. Finally, Dr. Rolston reviews the possibility of outpatient management of neutropenic fever. Recognizing that neutropenics represent a heterogeneous group of patients, identification of who can be treated as an outpatient and with what antibiotics are discussed.
Donowitz
G R
GR
University of Virginia Health System, Charlottesville 22908-1343, USA.
Maki
D G
DG
Crnich
C J
CJ
Pappas
P G
PG
Rolston
K V
KV
D000553:Ambulatory Care; D000890:Anti-Infective Agents / Q000627:therapeutic use / Q000633:toxicity; D002404:Catheterization / Q000009:adverse effects; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007239:Infections / Q000188:drug therapy* / Q000209:etiology; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
D000890:Anti-Infective Agents